Dec 27, 2024 9:00am EST 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
Dec 12, 2024 8:00am EST 180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules